Skip to main content
OpenTrials

Clinical trial condition

Locally Advanced Solid Tumor

Explore clinical trials studying Locally Advanced Solid Tumor. Study availability and eligibility vary by location and protocol.

31 public trials 16 recruiting studies
Refine in advanced search Browse all conditions

Locally Advanced Solid Tumor trial results

Recruiting

IBI3001 in Participants With Unresectable, Locally Advanced or Metastatic Solid Tumors

NCT06349408

Conditions
Locally Advanced Solid Tumor
Locations
  • Cancer Research SA Adelaide, South Australia, Australia
  • START Center for Cancer Research Los Angeles, California, United States
  • START Center for Cancer Research East Brunswick, New Jersey, United States
  • NEXT Oncology Dallas, Texas, United States
View all 27 locations
View Trial Details
Recruiting

A Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1)

NCT05118789

Conditions
Locally Advanced Solid Tumor, Metastatic Solid Tumor, Neoplasm Metastasis, +4 more
Locations
  • UCI Medical Center Orange, California, United States
  • Stanford Medicine Palo Alto, California, United States
  • UC Davis Comprehensive Cancer Center Sacramento, California, United States
  • University of Colorado Cancer Center Denver, Colorado, United States
View all 63 locations
View Trial Details
Recruiting

Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors

NCT05732831

Conditions
Adenocarcinoma, Adenoma, Carcinoma, +21 more
Locations
  • Stanford University Palo Alto, California, United States
  • Grand Valley Oncology Grand Junction, Colorado, United States
  • Florida Cancer Specialists & Research Institute Lake Mary, Florida, United States
  • Sylvester Comprehensive Cancer Center Miami, Florida, United States
View all 26 locations
View Trial Details
Recruiting

A Study to Assess the Safety, Tolerability, Pharmacokinetic, Pharmacodynamic, Immunogenicity and Antitumour Activity of IPN60300 in Adults With Locally Advanced or Metastatic Solid Tumours

NCT07213817

Conditions
Locally Advanced Solid Tumor, Metastatic Solid Tumor, Neoplasm Metastasis, +4 more
Locations
  • Yale Cancer Center-Yale University New Haven, Connecticut, United States
  • START Midwest Grand Rapids, Michigan, United States
  • Sidney Kimmel Cancer Center Philadelphia, Pennsylvania, United States
  • MD Anderson Cancer Center Houston, Texas, United States
View Trial Details
Recruiting

FOG-001 in Locally Advanced or Metastatic Solid Tumors

NCT05919264

Conditions
Adamantinomatous Craniopharyngioma, Adenocarcinoma, Adenoma, +65 more
Locations
  • Mayo Clinic Phoenix, Arizona, United States
  • Honor Health Scottsdale, Arizona, United States
  • Arizona Cancer Center at University of Arizona Tucson, Arizona, United States
  • University of California, Los Angeles (UCLA) Los Angeles, California, United States
View all 33 locations
View Trial Details
Recruiting

A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)

NCT05384626

Conditions
Locally Advanced Solid Tumor, Metastatic Solid Tumor, Neoplasm Metastasis, +4 more
Locations
  • University of California Irvine Medical Center Orange, California, United States
  • University of California, Davis Comprehensive Cancer Center Sacramento, California, United States
  • Stanford Cancer Institute Stanford, California, United States
  • University of Colorado Cancer Center Aurora, Colorado, United States
View all 74 locations
View Trial Details

Related conditions